830 related articles for article (PubMed ID: 32586724)
1. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
Yarza R; Bover M; Paredes D; López-López F; Jara-Casas D; Castelo-Loureiro A; Baena J; Mazarico JM; Folgueira MD; Meléndez-Carmona MÁ; Reyes A; Lumbreras C; Paz-Ares L; Díaz-Pedroche C; Gómez-Martín C
Eur J Cancer; 2020 Aug; 135():242-250. PubMed ID: 32586724
[TBL] [Abstract][Full Text] [Related]
2. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
[TBL] [Abstract][Full Text] [Related]
3. Serial serum SARS-CoV-2 RNA results in two COVID-19 cases with severe respiratory failure.
Kodama T; Kouzaki Y; Kawano S; Obinata H; Taniguchi H; Sasaki H; Ota S; Kawana A; Tamura K
J Infect Chemother; 2020 Nov; 26(11):1220-1223. PubMed ID: 32792249
[TBL] [Abstract][Full Text] [Related]
4. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
[TBL] [Abstract][Full Text] [Related]
5. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
6. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
Loarce-Martos J; García-Fernández A; López-Gutiérrez F; García-García V; Calvo-Sanz L; Del Bosque-Granero I; Terán-Tinedo MA; Boteanu A; Bachiller-Corral J; Vázquez-Díaz M
Rheumatol Int; 2020 Dec; 40(12):2015-2021. PubMed ID: 32945944
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
Lohse A; Klopfenstein T; Balblanc JC; Royer PY; Bossert M; Gendrin V; Charpentier A; Bozgan AM; Badie J; Bourgoin C; Contreras R; Mazurier I; Conrozier T; Zayet S
Microbes Infect; 2020 Oct; 22(9):500-503. PubMed ID: 32574789
[TBL] [Abstract][Full Text] [Related]
8. Early predictors for mechanical ventilation in COVID-19 patients.
Li W; Lin F; Dai M; Chen L; Han D; Cui Y; Pan P
Ther Adv Respir Dis; 2020; 14():1753466620963017. PubMed ID: 33054630
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumonia.
Tian J; Xu Q; Liu S; Mao L; Wang M; Hou X
Curr Med Res Opin; 2020 Nov; 36(11):1747-1752. PubMed ID: 32986475
[TBL] [Abstract][Full Text] [Related]
10. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
[No Abstract] [Full Text] [Related]
12. Association between obesity and clinical prognosis in patients infected with SARS-CoV-2.
Cai SH; Liao W; Chen SW; Liu LL; Liu SY; Zheng ZD
Infect Dis Poverty; 2020 Jun; 9(1):80. PubMed ID: 32600411
[TBL] [Abstract][Full Text] [Related]
13. Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.
Procopio G; Cancelliere A; Trecarichi EM; Mazzitelli M; Arrighi E; Perri G; Serapide F; Pelaia C; Lio E; Busceti MT; Pelle MC; Ricchio M; Scaglione V; Davoli C; Fusco P; La Gamba V; Torti C; Pelaia G
Ther Adv Respir Dis; 2020; 14():1753466620963016. PubMed ID: 33070706
[TBL] [Abstract][Full Text] [Related]
14. Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.
Ferguson J; Volk S; Vondracek T; Flanigan J; Chernaik A
J Clin Pharmacol; 2020 Nov; 60(11):1411-1415. PubMed ID: 32885463
[TBL] [Abstract][Full Text] [Related]
15. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.
Zahid U; Ramachandran P; Spitalewitz S; Alasadi L; Chakraborti A; Azhar M; Mikhalina G; Sherazi A; Narh JT; Khattar P; Bedi P
Am J Nephrol; 2020; 51(10):786-796. PubMed ID: 33011717
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
[No Abstract] [Full Text] [Related]
18. CPAP management of COVID-19 respiratory failure: a first quantitative analysis from an inpatient service evaluation.
Ashish A; Unsworth A; Martindale J; Sundar R; Kavuri K; Sedda L; Farrier M
BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33148777
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona.
Sisó-Almirall A; Kostov B; Mas-Heredia M; Vilanova-Rotllan S; Sequeira-Aymar E; Sans-Corrales M; Sant-Arderiu E; Cayuelas-Redondo L; Martínez-Pérez A; García-Plana N; Anguita-Guimet A; Benavent-Àreu J
PLoS One; 2020; 15(8):e0237960. PubMed ID: 32822413
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
